A mechanistic study on the tolerance of PAM distal end mismatch by SpCas9

Dhritiman Dey1, Rudra Chakravarti1, Oindrila Bhattacharjee2

  • 1Department of Natural Products, National Institute of Pharmaceutical Education and Research, Kolkata, West Bengal, India.

Insights

CRISPR-Cas9 gene editing

Area of Science:

  • Molecular Biology
  • Biotechnology
  • Bioinformatics

Background:

  • CRISPR-Cas9 technology offers revolutionary gene editing capabilities.
  • Therapeutic applications are hindered by unintended off-target mutations.
  • Understanding SpCas9 off-target activity is crucial for safe clinical use.

Purpose of the Study:

  • To investigate the impact of mismatches at the PAM-distal end on SpCas9 off-target activity.
  • To elucidate the structural mechanisms underlying SpCas9 binding and cleavage.
  • To improve the prediction of CRISPR-Cas9 off-target effects.

Main Methods:

  • Designed and synthesized DNA targets with varying mismatches near the PAM sequence.
  • Conducted in vitro biochemical assays and cell line-based experiments to assess Cas9 activity.
  • Utilized Molecular Dynamics (MD) simulations to analyze RNA-DNA duplex stability and conformational changes.

Main Results:

  • Demonstrated a strong correlation between mismatch location/nature and SpCas9 activity.
  • Observed significantly reduced or abolished Cas9 activity at target sites with multiple mismatches (positions 15-18 upstream of PAM).
  • MD simulations revealed that specific mismatches induce conformational instability in the RNA-DNA duplex, correlating with reduced activity.

Conclusions:

  • Off-target activity of SpCas9 is strongly influenced by mismatches at the PAM-distal region.
  • RNA-DNA duplex stability is a critical factor in determining SpCas9 target recognition and cleavage efficiency.
  • Integrating duplex stability with binding energy calculations can enhance the prediction accuracy of CRISPR-Cas9 off-target effects.

Related Concept Videos

Homologous Recombination02:31

Homologous Recombination

The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...
50.4K
CRISPR01:59

CRISPR

Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
50.6K
Conservative Site-specific Recombination and Phase Variation02:53

Conservative Site-specific Recombination and Phase Variation

Because the DNA segments are cut and reorganized in a direction-specific manner, site-specific recombination has emerged as an efficient genetic engineering technique. Flippase and Cyclization recombinases or Flp and Cre, respectively, are two members of the tyrosine recombinase family derived from bacteriophages, that are used to mediate site-specific DNA insertions, deletions, and targeted expression of proteins in mammalian cell lines.
The recognition sites for Cre recombinase called LoxP...
6.0K